Home Markets Aurobindo Pharma Outperforms Expectations with Strong Q4, Eyes Robust Growth Ahead

Aurobindo Pharma Outperforms Expectations with Strong Q4, Eyes Robust Growth Ahead

May 28, 2024 comments off

Original source: https://www.investing.com/news/stock-market-news/aurobindo-pharma-outperforms-expectations-with-strong-q4-eyes-robust-growth-ahead-3457980

You May Also Like

S&P Dow Jones Indices considers new index rules as mega IPOs loom

US resumes commercial passenger air service to Venezuela after seven years

Hemab Therapeutics prices IPO at $18 per share

First Tesla Semi rolls off high volume production line

Samsung Electronics sees robust AI demand after Q1 chip profit jumps almost 50-fold

Samsung Electronics expects to win more customers for advanced logic chips